Publications

The publications table below contains a list of all publications affiliated with the Save Sight Registries. 
The list can be searched by Author (e.g. Mark Gillies) or by SSR module (e.g. FRB, AMD, DME) or by any text visible in the list.

TitlePublication dateJournalLinkauthorsPublication Categoriespublication_id
Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness!Apr-2024Ophthalmology RetinaPUBMEDSocorro Alforja, Adrian Hunt, Vuong Nguyen, Louise O’Toole, Pierre-Henry Gabrielle, Alessandro Invernizzi, Hemal Mehta, Theodorus Leonardus Ponsioen, David Squirrell, Ricardo P Casaroli-Marano, Daniel Barthelmes, Mark C Gillies, Javier Zarranz-Ventura; Fight Retinal Blindness (FRB) users groupRetina>RVO>FRB69
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registryApr-2024Ophthalmology RetinaPUBMEDHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret, Jennifer Arnold, Tremeur Guillaumie, Wajiha Jurdi Kheir, Gerhard Kok, Stela Vujosevic, Louise O’Toole, Els Mangelschots, Nandor Jaross, Lala Ceklic, Vincent Daien, Francesco Viola, David Squirrell, Francisco Javier Lavid, Catherine Creuzot-Garcher, Daniel Barthelmes, Mark Gillies; Fight Retinal Blindness! Study GroupRetina>DME>FRB68
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registryMar-2024Scientific ReportsPUBMEDGonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-VenturaRetina>RVO>FRB67
Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! RegistryJan-2024Ophthalmology. Retina, (epub)PUBMEDClotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry GabrielleRetina>AMD>FRB66
Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular DegenerationNov-2023Ophthalmology. Retina, (epub)PUBMEDJordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES4
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in CaucasiansNov-2023Clinical and Experimental OphthalmologyPUBMEDMatteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco ViolaRetina>AMD>FRB65
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life ExperienceOct-2023Ophthalmology and TherapyPUBMEDEloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study GroupRetina>DME>FRB64
Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP RegistriesSep-2023British Journal of Ophthalmology, (epub)PUBMEDCaroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas StahlRetina>ROP>FRB
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryJun-2023British Journal of OphthalmologyPUBMEDAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C GilliesRetina>RVO>FRB52
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionApr-2023EyePUBMEDSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark GilliesRetina>AMD|Retina>DME|Retina>RVO>FRB58
Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration Mar-2023RetinaPUBMEDElisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB63
Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degenerationFeb-2023RetinaPUBMEDKelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB51
Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registryDec-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB57
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registryDec-2022Acta OphthalmologicaPUBMEDJorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB62
Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysisDec-2022Advances in TherapyPUBMEDHemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C GilliesRetina>DME>FRB2
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionDec-2022Clinical and Experimental OphthalmologyPUBMEDNancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David SquirrellRetina>RVO>FRB60
Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry Nov-2022Ophthalmol RetinaPUBMEDAdrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark GilliesRetina>RVO>FRB61
Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! RegistryNov-2022Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD|Retina>DME|Retina>RVO>FRB59
Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! ProjectJul-2022Acta OphthalmologicaPUBMEDJanika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-BellRetina>DME>FRB56
Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! projectJun-2022Acta OphthalmologicaPUBMEDMateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel BarthelmesRetina>RVO>FRB48
12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryJun-2022British Journal of OphthalmologyPUBMEDAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal MehtaRetina>RVO>FRB44
Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! RegistryJun-2022RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark GilliesRetina>DME>FRB54
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! RegistryMay-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>DME>FRB40
Quality of life impact of eye diseases: a Save Sight Registries studyMay-2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L WatsonRetina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB53
International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registryApr-2022RetinaPUBMEDJavier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committeeRetina>AMD|Retina>DME|Retina>RVO>FRB50
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! RegistryApr-2022Ophthalmology and TherapyPUBMEDSanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-GarcherRetina>DME>FRB55
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomesApr-2022Clinical and Experimental OphthalmologyPUBMEDJavier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES2
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistryMar-2022EyePUBMEDSanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark GilliesRetina>DME>FRB43
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! RegistryFeb-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel BarthelmesRetina>CNV>FRB45
The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degenerationJan-2022RetinaPUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB47
Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal FibrosisNov-2021Translational vision science & technologyPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>AMD>FRB49
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceOct-2021EyePUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy CheungRetina>AMD>FRB42
Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the NetherlandsSep-2021Acta OphthalmologicaPUBMEDFrank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W KlaverRetina>AMD>FRBNL1
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registrySep-2021Clinical & Experimental OphthalmologyPUBMEDVuong Nguyen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterAug-2021Clinical and Experimental OphthalmologyPUBMEDElisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB46
Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGFJul-2021RetinaPUBMEDVuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB41
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registryJun-2021Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDMarc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-VenturaRetina>AMD>FRBES1
Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! ProjectJan-2021RetinaPUBMEDElisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB35
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular DegenerationDec-2020JAMA OphthalmologyPUBMEDRobert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark GilliesRetina>AMD>FRB39
Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degenerationDec-2020RetinaPUBMEDKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB34
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! RegistrySep-2020Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>FRB38
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020Clinical and Experimental OphthalmologyPUBMEDShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB37
Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020RetinaPUBMEDAlexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB28
Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight RegistriesSep-2020Journal Français d'OphtalmologiePUBMEDM Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P NguyenRetina>DME>FRBFR2
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS StudySep-2020Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy CheungRetina>AMD>FRBSG1
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! RegistryAug-2020Clinical and Experimental OphthalmologyPUBMEDAnne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel BarthelmesRetina>DME>FRB36
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! projectAug-2020British Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigatorsRetina>AMD>FRB32
Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!Jul-2020Journal Français d'OphtalmologiePUBMEDLestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher CRetina>AMD>FRBFR1
Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French studyJul-2020Clinical and Experimental OphthalmologyPUBMEDBenjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark GilliesRetina>AMD>FRBFR3
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! RegistryMay-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel BarthelmesRetina>DME>FRB33
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! RegistryMay-2020Clinical and Experimental OphthalmologyPUBMEDSanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C GilliesRetina>DME>FRB31
Assessing the accuracy of a large observational registry of neovascular age-related macular degenerationMay-2020RetinaPUBMEDVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB25
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! RegistryMar-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel BarthelmesRetina>AMD>FRB30
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsFeb-2020American Journal of OphthalmologyPUBMEDMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRB29
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 monthsSep-2019British Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB23
Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 MonthsAug-2019Ophthalmology RetinaPUBMEDVuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB27
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! ProjectAug-2019American Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark GilliesRetina>CNV>FRB26
Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based studyAug-2019British Journal of OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB21
Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor AgentsMay-2019OphthalmologyPUBMEDChu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study GroupRetina>AMD>FRB24
Clinical Registries in OphthalmologyMay-2019OphthalmologyPUBMEDJeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L WatsonCornea|Retina>FRB>FCBC2
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! CohortMar-2019Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark GilliesRetina>FRB22
Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular DegenerationJan-2019OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB20
A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! ProjectOct-2018Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDDaniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study GroupRetina>AMD>FRB19
Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational StudyOct-2018RetinaPUBMEDAnagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRBAU4
Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! ProjectJun-2018American Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB18
Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational StudyJun-2018Ophthalmology RetinaPUBMEDEugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB17
Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licenceMay-2018Clinical and Experimental OphthalmologyPUBMEDMehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal MehtaRetina>AMD>FRBUK1
Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set.Apr-2018Clinical and Experimental OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB16
Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationFeb-2018OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB15
Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular DegenerationJan-2018OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB14
Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degenerationJan-2018RetinaPUBMEDDaniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB11
Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsMar-2017OphthalmologyPUBMEDMark C Gillies, Vincent Daien, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRBAU3
Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMDFeb-2017OphthalmologyPUBMEDHessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB13
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyDec-2016Ophthalmology PUBMEDMark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB12
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDec-2016British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB9
Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular DegenerationNov-2016OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB10
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational StudySep-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study GroupRetina>AMD>FRB8
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJun-2015OphthalmologyPUBMEDJennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB7
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMar-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study GroupRetina>AMD>FRB6
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataMar-2015British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB3
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degenerationDec-2014Acta OphthalmologicaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU1
Intravitreal therapy in bilateral neovascular age-related macular degenerationOct-2014OphthalmologyPUBMEDDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB5
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degenerationSep-2014RetinaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU2
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMar-2014OphthalmologyPUBMEDMark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB4
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! ProjectJan-2014RetinaPUBMEDMark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel BarthelmesRetina>AMD>FRB1
Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve EyesAug-2013Investigative Ophthalmology and Visual SciencePUBMEDMark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB2
TitlePublication dateJournalLinkauthorsPublication Categoriespublication_id
Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry Jan 2024Eye (London, England)PUBMEDHimal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson Cornea>Keratoconus>FCBC19
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysisNov 2023Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub)PUBMEDGrace A Borchert, Himal Kandel, Stephanie L WatsonCornea>Keratoconus>FCBC21
Evaluation of ocular neuropathic painOct 2023The Ocular SurfacePUBMEDDamien Tuan-Man Le, Himal Kandel, Stephanie L WatsonCornea>Dry Eye>FCBC20
Mental Health Impact of Keratoconus: A Systematic ReviewSep 2023CorneaPUBMEDEmily Durakovic, Himal Kandel, Stephanie L Watson>FCBC17
Opportunities and challenges for clinical registriesMay 2023Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Mark C Gillies, Stephanie L Watson Cornea>FCBC18
Clinical Registries in Dry Eye Disease: A Systematic ReviewDec 2022CorneaPUBMEDPauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson Cornea>Dry Eye>FCBC15
Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus RegistryDec 2022CorneaPUBMEDHimal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L WatsonCornea>Keratoconus>FCBC16
Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry StudyOct 2022Clinical and Experimental OphthalmologyPUBMEDAlex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L WatsonCornea>Keratoconus>FCBC14
Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-AnalysisSep 2022Asia-Pacific Journal of OphthalmologyPUBMEDGrace A Borchert, Stephanie L Watson, Himal KandelCornea>Keratoconus>FCBC13
Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry studySep 2022British Journal of OphthalmologyPUBMEDAlex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie WatsonCornea>Keratoconus>FCBC8
Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry StudyAug 2022CorneaPUBMEDHimal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L WatsonCornea>Keratoconus>FCBC12
Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry StudyMay 2022CorneaPUBMEDBlanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L WatsonCornea>Keratoconus>FCBC11
Quality of life impact of eye diseases: a Save Sight Registries studyMay 2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L WatsonRetina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB53
The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye careJan 2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC10
Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry StudyDec 2021CorneaPUBMEDHimal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L WatsonCornea>Keratoconus>FCBC9
Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal EctasiaJan 2021Asia-Pacific Journal of OphthalmologyPUBMEDPauline Khoo, Maria Cabrera-Aguas, Stephanie L WatsonCornea>Keratoconus>FCBC7
The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital SettingApr 2020CorneaPUBMEDAlex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1Cornea>Keratoconus>FCBC6
Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry StudyMar 2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC5
Measurement of Quality of Life in KeratoconusMar 2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Stephanie L WatsonCornea>Keratoconus>FCBC4
Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 EyesJul 2019OphthalmologyPUBMEDAlex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L WatsonCornea>Keratoconus>FCBC3
Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry StudyMay 2019CorneaPUBMEDJeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L WatsonCornea>Keratoconus>FCBC1
Clinical Registries in OphthalmologyMay 2019OphthalmologyPUBMEDJeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L WatsonCornea|Retina>FRB>FCBC2
TitlePublication dateJournalLinkauthorsPublication Categoriespublication_id
Outcomes of iStent inject combined with cataract surgery in Asian eyes: Australian data from the Fight Glaucoma Blindness international registryApr-2024International OphthalmologyPUBMEDBrandon Huynh, Getiye Kibret, David Wechsler, Anne Lee, Ridia Lim, Colin Clement, Mitchell LawlorGlaucoma>FGBG3
Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgeryApr-2022Clinical and Experimental OphthalmologyPUBMEDDavid P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell LawlorGlaucoma>FGBG2
Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! RegistryNov-2021BMJ Open OphthalmologyPUBMEDMitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark GilliesGlaucoma>FGBG1
TitlePublication dateJournalLinkauthorsPublication Categoriespublication_id
Outcomes of iStent inject combined with cataract surgery in Asian eyes: Australian data from the Fight Glaucoma Blindness international registryApr-2024International OphthalmologyPUBMEDBrandon Huynh, Getiye Kibret, David Wechsler, Anne Lee, Ridia Lim, Colin Clement, Mitchell LawlorGlaucoma>FGBG3
Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness!Apr-2024Ophthalmology RetinaPUBMEDSocorro Alforja, Adrian Hunt, Vuong Nguyen, Louise O’Toole, Pierre-Henry Gabrielle, Alessandro Invernizzi, Hemal Mehta, Theodorus Leonardus Ponsioen, David Squirrell, Ricardo P Casaroli-Marano, Daniel Barthelmes, Mark C Gillies, Javier Zarranz-Ventura; Fight Retinal Blindness (FRB) users groupRetina>RVO>FRB69
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registryApr-2024Ophthalmology RetinaPUBMEDHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret, Jennifer Arnold, Tremeur Guillaumie, Wajiha Jurdi Kheir, Gerhard Kok, Stela Vujosevic, Louise O’Toole, Els Mangelschots, Nandor Jaross, Lala Ceklic, Vincent Daien, Francesco Viola, David Squirrell, Francisco Javier Lavid, Catherine Creuzot-Garcher, Daniel Barthelmes, Mark Gillies; Fight Retinal Blindness! Study GroupRetina>DME>FRB68
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registryMar-2024Scientific ReportsPUBMEDGonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-VenturaRetina>RVO>FRB67
Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! RegistryJan-2024Ophthalmology. Retina, (epub)PUBMEDClotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry GabrielleRetina>AMD>FRB66
Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry Jan-2024Eye (London, England)PUBMEDHimal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson Cornea>Keratoconus>FCBC19
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysisNov-2023Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub)PUBMEDGrace A Borchert, Himal Kandel, Stephanie L WatsonCornea>Keratoconus>FCBC21
Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular DegenerationNov-2023Ophthalmology. Retina, (epub)PUBMEDJordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES4
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in CaucasiansNov-2023Clinical and Experimental OphthalmologyPUBMEDMatteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco ViolaRetina>AMD>FRB65
Evaluation of ocular neuropathic painOct-2023The Ocular SurfacePUBMEDDamien Tuan-Man Le, Himal Kandel, Stephanie L WatsonCornea>Dry Eye>FCBC20
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life ExperienceOct-2023Ophthalmology and TherapyPUBMEDEloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study GroupRetina>DME>FRB64
Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP RegistriesSep-2023British Journal of Ophthalmology, (epub)PUBMEDCaroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas StahlRetina>ROP>FRB
Mental Health Impact of Keratoconus: A Systematic ReviewSep-2023CorneaPUBMEDEmily Durakovic, Himal Kandel, Stephanie L Watson>FCBC17
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryJun-2023British Journal of OphthalmologyPUBMEDAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C GilliesRetina>RVO>FRB52
Opportunities and challenges for clinical registriesMay-2023Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Mark C Gillies, Stephanie L Watson Cornea>FCBC18
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionApr-2023EyePUBMEDSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark GilliesRetina>AMD|Retina>DME|Retina>RVO>FRB58
Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration Mar-2023RetinaPUBMEDElisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB63
Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degenerationFeb-2023RetinaPUBMEDKelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB51
Clinical Registries in Dry Eye Disease: A Systematic ReviewDec-2022CorneaPUBMEDPauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson Cornea>Dry Eye>FCBC15
Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus RegistryDec-2022CorneaPUBMEDHimal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L WatsonCornea>Keratoconus>FCBC16
Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registryDec-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB57
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registryDec-2022Acta OphthalmologicaPUBMEDJorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB62
Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysisDec-2022Advances in TherapyPUBMEDHemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C GilliesRetina>DME>FRB2
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionDec-2022Clinical and Experimental OphthalmologyPUBMEDNancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David SquirrellRetina>RVO>FRB60
Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry Nov-2022Ophthalmol RetinaPUBMEDAdrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark GilliesRetina>RVO>FRB61
Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! RegistryNov-2022Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD|Retina>DME|Retina>RVO>FRB59
Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry StudyOct-2022Clinical and Experimental OphthalmologyPUBMEDAlex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L WatsonCornea>Keratoconus>FCBC14
Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-AnalysisSep-2022Asia-Pacific Journal of OphthalmologyPUBMEDGrace A Borchert, Stephanie L Watson, Himal KandelCornea>Keratoconus>FCBC13
Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry studySep-2022British Journal of OphthalmologyPUBMEDAlex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie WatsonCornea>Keratoconus>FCBC8
Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry StudyAug-2022CorneaPUBMEDHimal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L WatsonCornea>Keratoconus>FCBC12
Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! ProjectJul-2022Acta OphthalmologicaPUBMEDJanika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-BellRetina>DME>FRB56
Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! projectJun-2022Acta OphthalmologicaPUBMEDMateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel BarthelmesRetina>RVO>FRB48
12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryJun-2022British Journal of OphthalmologyPUBMEDAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal MehtaRetina>RVO>FRB44
Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! RegistryJun-2022RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark GilliesRetina>DME>FRB54
Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry StudyMay-2022CorneaPUBMEDBlanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L WatsonCornea>Keratoconus>FCBC11
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! RegistryMay-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>DME>FRB40
Quality of life impact of eye diseases: a Save Sight Registries studyMay-2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L WatsonRetina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB53
International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registryApr-2022RetinaPUBMEDJavier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committeeRetina>AMD|Retina>DME|Retina>RVO>FRB50
Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgeryApr-2022Clinical and Experimental OphthalmologyPUBMEDDavid P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell LawlorGlaucoma>FGBG2
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! RegistryApr-2022Ophthalmology and TherapyPUBMEDSanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-GarcherRetina>DME>FRB55
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomesApr-2022Clinical and Experimental OphthalmologyPUBMEDJavier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES2
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistryMar-2022EyePUBMEDSanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark GilliesRetina>DME>FRB43
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! RegistryFeb-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel BarthelmesRetina>CNV>FRB45
The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degenerationJan-2022RetinaPUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB47
The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye careJan-2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC10
Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry StudyDec-2021CorneaPUBMEDHimal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L WatsonCornea>Keratoconus>FCBC9
Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! RegistryNov-2021BMJ Open OphthalmologyPUBMEDMitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark GilliesGlaucoma>FGBG1
Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal FibrosisNov-2021Translational vision science & technologyPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>AMD>FRB49
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceOct-2021EyePUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy CheungRetina>AMD>FRB42
Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the NetherlandsSep-2021Acta OphthalmologicaPUBMEDFrank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W KlaverRetina>AMD>FRBNL1
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registrySep-2021Clinical & Experimental OphthalmologyPUBMEDVuong Nguyen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterAug-2021Clinical and Experimental OphthalmologyPUBMEDElisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB46
Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGFJul-2021RetinaPUBMEDVuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB41
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registryJun-2021Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDMarc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-VenturaRetina>AMD>FRBES1
Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal EctasiaJan-2021Asia-Pacific Journal of OphthalmologyPUBMEDPauline Khoo, Maria Cabrera-Aguas, Stephanie L WatsonCornea>Keratoconus>FCBC7
Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! ProjectJan-2021RetinaPUBMEDElisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB35
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular DegenerationDec-2020JAMA OphthalmologyPUBMEDRobert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark GilliesRetina>AMD>FRB39
Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degenerationDec-2020RetinaPUBMEDKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB34
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! RegistrySep-2020Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>FRB38
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020Clinical and Experimental OphthalmologyPUBMEDShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB37
Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020RetinaPUBMEDAlexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB28
Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight RegistriesSep-2020Journal Franc?ais d'OphtalmologiePUBMEDM Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P NguyenRetina>DME>FRBFR2
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS StudySep-2020Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy CheungRetina>AMD>FRBSG1
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! RegistryAug-2020Clinical and Experimental OphthalmologyPUBMEDAnne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel BarthelmesRetina>DME>FRB36
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! projectAug-2020British Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigatorsRetina>AMD>FRB32
Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!Jul-2020Journal Franc?ais d'OphtalmologiePUBMEDLestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher CRetina>AMD>FRBFR1
Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French studyJul-2020Clinical and Experimental OphthalmologyPUBMEDBenjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark GilliesRetina>AMD>FRBFR3
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! RegistryMay-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel BarthelmesRetina>DME>FRB33
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! RegistryMay-2020Clinical and Experimental OphthalmologyPUBMEDSanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C GilliesRetina>DME>FRB31
Assessing the accuracy of a large observational registry of neovascular age-related macular degenerationMay-2020RetinaPUBMEDVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB25
The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital SettingApr-2020CorneaPUBMEDAlex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1Cornea>Keratoconus>FCBC6
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! RegistryMar-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel BarthelmesRetina>AMD>FRB30
Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry StudyMar-2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC5
Measurement of Quality of Life in KeratoconusMar-2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Stephanie L WatsonCornea>Keratoconus>FCBC4
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsFeb-2020American Journal of OphthalmologyPUBMEDMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRB29
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 monthsSep-2019British Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB23
Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 MonthsAug-2019Ophthalmology RetinaPUBMEDVuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB27
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! ProjectAug-2019American Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark GilliesRetina>CNV>FRB26
Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based studyAug-2019British Journal of OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB21
Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 EyesJul-2019OphthalmologyPUBMEDAlex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L WatsonCornea>Keratoconus>FCBC3
Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor AgentsMay-2019OphthalmologyPUBMEDChu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study GroupRetina>AMD>FRB24
Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry StudyMay-2019CorneaPUBMEDJeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L WatsonCornea>Keratoconus>FCBC1
Clinical Registries in OphthalmologyMay-2019OphthalmologyPUBMEDJeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L WatsonCornea|Retina>FRB>FCBC2
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! CohortMar-2019Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark GilliesRetina>FRB22
Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular DegenerationJan-2019OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB20
A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! ProjectOct-2018Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDDaniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study GroupRetina>AMD>FRB19
Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational StudyOct-2018RetinaPUBMEDAnagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRBAU4
Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! ProjectJun-2018American Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB18
Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational StudyJun-2018Ophthalmology RetinaPUBMEDEugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB17
Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licenceMay-2018Clinical and Experimental OphthalmologyPUBMEDMehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal MehtaRetina>AMD>FRBUK1
Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set.Apr-2018Clinical and Experimental OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB16
Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationFeb-2018OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB15
Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular DegenerationJan-2018OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB14
Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degenerationJan-2018RetinaPUBMEDDaniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB11
Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsMar-2017OphthalmologyPUBMEDMark C Gillies, Vincent Daien, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRBAU3
Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMDFeb-2017OphthalmologyPUBMEDHessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB13
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyDec-2016Ophthalmology PUBMEDMark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB12
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDec-2016British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB9
Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular DegenerationNov-2016OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB10
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational StudySep-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study GroupRetina>AMD>FRB8
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJun-2015OphthalmologyPUBMEDJennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB7
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMar-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study GroupRetina>AMD>FRB6
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataMar-2015British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB3
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degenerationDec-2014Acta OphthalmologicaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU1
Intravitreal therapy in bilateral neovascular age-related macular degenerationOct-2014OphthalmologyPUBMEDDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB5
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degenerationSep-2014RetinaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU2
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMar-2014OphthalmologyPUBMEDMark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB4
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! ProjectJan-2014RetinaPUBMEDMark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel BarthelmesRetina>AMD>FRB1
Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve EyesAug-2013Investigative Ophthalmology and Visual SciencePUBMEDMark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB2
TitlePublication dateJournalLinkauthorsPublication Categoriespublication_id
Outcomes of iStent inject combined with cataract surgery in Asian eyes: Australian data from the Fight Glaucoma Blindness international registryApr-2024International OphthalmologyPUBMEDBrandon Huynh, Getiye Kibret, David Wechsler, Anne Lee, Ridia Lim, Colin Clement, Mitchell LawlorGlaucoma>FGBG3
Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness!Apr-2024Ophthalmology RetinaPUBMEDSocorro Alforja, Adrian Hunt, Vuong Nguyen, Louise O’Toole, Pierre-Henry Gabrielle, Alessandro Invernizzi, Hemal Mehta, Theodorus Leonardus Ponsioen, David Squirrell, Ricardo P Casaroli-Marano, Daniel Barthelmes, Mark C Gillies, Javier Zarranz-Ventura; Fight Retinal Blindness (FRB) users groupRetina>RVO>FRB69
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registryApr-2024Ophthalmology RetinaPUBMEDHemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret, Jennifer Arnold, Tremeur Guillaumie, Wajiha Jurdi Kheir, Gerhard Kok, Stela Vujosevic, Louise O’Toole, Els Mangelschots, Nandor Jaross, Lala Ceklic, Vincent Daien, Francesco Viola, David Squirrell, Francisco Javier Lavid, Catherine Creuzot-Garcher, Daniel Barthelmes, Mark Gillies; Fight Retinal Blindness! Study GroupRetina>DME>FRB68
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registryMar-2024Scientific ReportsPUBMEDGonzaga Garay-Aramburu, Adrian Hunt, Carolina Arruabarrena, Hemal Mehta, Alessandro Invernizzi, Pierre-Henry Gabrielle, Tremeur Guillaumie, Benjamin Wolff, Mark C Gillies, Javier Zarranz-VenturaRetina>RVO>FRB67
Real-world unmet needs in the management of poorly responsive neovascular age-related macular degeneration in Europe: data from the FRB! RegistryJan-2024Ophthalmology. Retina, (epub)PUBMEDClotilde Boudousq, Vuong Nguyen, Adrian Hunt, Mark Gillies, Javier Zarranz-Ventura, Louise O’Toole, Els Mangelschots, Pavol Kusenda, Ursula Schmidt-Erfurdt, Andreas Pollreisz, Wajiha Jurdi Kheir, Carolina Arruabarrena, Stela Vujosevic, Daniel Barthelmes, Catherine Creuzot-Garcher, Pierre-Henry GabrielleRetina>AMD>FRB66
Comparison of standard versus accelerated corneal collagen cross-linking for keratoconus: 5-year outcomes from the Save Sight Keratoconus Registry Jan-2024Eye (London, England)PUBMEDHimal Kandel, Marco Abbondanza, Aanchal Gupta, Richard Mills, Adam S Watson, Constantinos Petsoglou, Yves Kerdraon, Stephanie L Watson Cornea>Keratoconus>FCBC19
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysisNov-2023Graefe’s Archive for Clinical and Experimental Ophthalmology, (epub)PUBMEDGrace A Borchert, Himal Kandel, Stephanie L WatsonCornea>Keratoconus>FCBC21
Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular DegenerationNov-2023Ophthalmology. Retina, (epub)PUBMEDJordi Izquierdo-Serra, Ruben Martin-Pinardel, Aina Moll-Udina, Carolina Bernal-Morales, Gonzaga Garay-Aramburu, Jorge Sanchez-Monroy, Carolina Arruabarrena, Ana Fernandez-Hortelano, Marta S Figueroa, Maximino Abraldes, Francisco Javier Lavid de Los Mozos, Miguel Angel Zapata, Jose Maria Ruiz-Moreno, Laura Broc-Iturralde, Jacobo Gonzalez-Guijarro, Jose Juan Escobar-Barranco, Roberto Gallego-Pinazo, Alba Parrado-Carrillo, Marina Dotti-Boada, Socorro Alforja, Marc Figueras-Roca, Daniel Barthelmes, Mark C Gillies, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura; Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES4
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in CaucasiansNov-2023Clinical and Experimental OphthalmologyPUBMEDMatteo Airaldi, Alessandro Invernizzi, Vuong Nguyen, Stela Vujosevic, Federico Ricci, Pietro Monaco, Marco Nassisi, Daniel Barthelmes, Mark Gillies, Francesco ViolaRetina>AMD>FRB65
Evaluation of ocular neuropathic painOct-2023The Ocular SurfacePUBMEDDamien Tuan-Man Le, Himal Kandel, Stephanie L WatsonCornea>Dry Eye>FCBC20
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life ExperienceOct-2023Ophthalmology and TherapyPUBMEDEloi Debourdeau, Robin Medard, Chloe Chamard, Vuong Nguyen, Pierre Henry Gabrielle, Catherine Creuzot-Garcher, Sandrine Allieu, Mark C Gillies, Daniel Barthelmes, Vincent Daien; Fight Retinal Blindness! Study GroupRetina>DME>FRB64
Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP RegistriesSep-2023British Journal of Ophthalmology, (epub)PUBMEDCaroline Catt, Johanna M Pfeil, Daniel Barthelmes, Glen A Gole, Tim U Krohne, Wei-Chi Wu, Shunji Kusaka, Peiquan Zhao, Shuan Dai, James Elder, Matthias Heckmann, Jacqueline Stack, Gigi Khonyongwa-Fernandez, Andreas StahlRetina>ROP>FRB
Mental Health Impact of Keratoconus: A Systematic ReviewSep-2023CorneaPUBMEDEmily Durakovic, Himal Kandel, Stephanie L Watson>FCBC17
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryJun-2023British Journal of OphthalmologyPUBMEDAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C GilliesRetina>RVO>FRB52
Opportunities and challenges for clinical registriesMay-2023Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Mark C Gillies, Stephanie L Watson Cornea>FCBC18
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionApr-2023EyePUBMEDSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, Pierre-Henry Gabrielle, Francesco Viola, Hemal Mehta, Les Manning, David Squirrell, Jennifer Arnold, Ian L McAllister, Daniel Barthelmes, Mark GilliesRetina>AMD|Retina>DME|Retina>RVO>FRB58
Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration Mar-2023RetinaPUBMEDElisa E Cornish, Vuong Nguyen, Martin Puzo, Louise O'Toole, Chui M Gemmy Cheung, Andrea Vincent, Tremeur Guillaumie, Sioe Lan Oei, Helena Brosa Morros, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB63
Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degenerationFeb-2023RetinaPUBMEDKelvin Y C Teo, Vuong Nguyen, Louise O'Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB51
Clinical Registries in Dry Eye Disease: A Systematic ReviewDec-2022CorneaPUBMEDPauline Khoo, Laura E Downie, Fiona Stapleton, Saaeha Rauz, Vincent Daien, Francisco Arnalich, David Mingo, and Stephanie L Watson Cornea>Dry Eye>FCBC15
Cross-linking improves the quality of life of people with Keratoconus: A cross-sectional and longitudinal study from the Save Sight Keratoconus RegistryDec-2022CorneaPUBMEDHimal Kandel, Jern Yee Chen, Srujana Sahebjada, Elaine W Chong, Steven Wiffen, Stephanie L WatsonCornea>Keratoconus>FCBC16
Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registryDec-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Samuel Maitrias, Vuong Nguyen, Jennifer J Arnold, David Squirrell, Louis Arnould, Jorge Sanchez-Monroy, Francesco Viola, Louise O'Toole, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB57
Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registryDec-2022Acta OphthalmologicaPUBMEDJorge Sánchez-Monroy, Vuong Nguyen, Martin Puzo, Pilar Calvo, Carolina Arruabarrena, Pietro Monaco, Michael Chilov, David Keegan, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB62
Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysisDec-2022Advances in TherapyPUBMEDHemal Mehta, Vuong Nguyen, Daniel Barthelmes, Suzann Pershing, Gloria C Chi, Pamela Dopart, Mark C GilliesRetina>DME>FRB2
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionDec-2022Clinical and Experimental OphthalmologyPUBMEDNancy Wang, Adrian Hunt, Vuong Nguyen, Janika Shah, Samantha Fraser-Bell, Ian McAllister, Daniel Barthelmes, Mark Gillies, David SquirrellRetina>RVO>FRB60
Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry Nov-2022Ophthalmol RetinaPUBMEDAdrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, Theodorus Ponsioen, Ian L McAllister, Jennifer Arnold, Stephanie Young, Pierre-Henry Gabrielle, Hemal Mehta, Louise O' Toole, Socorro Alforja, Javier Zarranz-Ventura, Daniel Barthelmes, Mark GilliesRetina>RVO>FRB61
Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! RegistryNov-2022Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Louis Arnould, Francesco Viola, Javier Zarranz-Ventura, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD|Retina>DME|Retina>RVO>FRB59
Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry StudyOct-2022Clinical and Experimental OphthalmologyPUBMEDAlex C Ferdi, Himal Kandel, Vuong Nguyen, Jeremy Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie L WatsonCornea>Keratoconus>FCBC14
Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-AnalysisSep-2022Asia-Pacific Journal of OphthalmologyPUBMEDGrace A Borchert, Stephanie L Watson, Himal KandelCornea>Keratoconus>FCBC13
Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry studySep-2022British Journal of OphthalmologyPUBMEDAlex Ferdi, Vuong Nguyen, Himal Kandel, Jeremy C K Tan, Francisco Arnalich-Montiel, Marco Abbondanza, Stephanie WatsonCornea>Keratoconus>FCBC8
Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry StudyAug-2022CorneaPUBMEDHimal Kandel, Konrad Pesudovs , Vuong Nguyen, Jern Yee Chen, Alexander Poon, Richard Mills, Stephanie L WatsonCornea>Keratoconus>FCBC12
Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! ProjectJul-2022Acta OphthalmologicaPUBMEDJanika Shah, Vuong Nguyen, Adrian Hunt, Hemal Mehta, Barbara Romero-Nuñez, Javier Zarranz-Ventura, Francesco Viola, Walid Bougamha, Rachel Barnes, Daniel Barthelmes, Mark C Gillies, Samantha Fraser-BellRetina>DME>FRB56
Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! projectJun-2022Acta OphthalmologicaPUBMEDMateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, Hemal Mehta, Catherine Creuzot-Garcher, Pierre-Henry Gabrielle, Martin Guillemin, Samantha Fraser-Bell, Jennifer Arnold, Ian L McAllister, Mark Gillies, Daniel BarthelmesRetina>RVO>FRB48
12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registryJun-2022British Journal of OphthalmologyPUBMEDAdrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, Socorro Alforja, Pierre-Henry Gabrielle, Javier Zarranz-Ventura, Martin Guillemin, Samantha Fraser-Bell, Ricardo P Casaroli Marano, Jennifer Arnold, Ian L McAllister, Louise O'Toole, Mark C Gillies, Daniel Barthelmes, Hemal MehtaRetina>RVO>FRB44
Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! RegistryJun-2022RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Jennifer J Arnold, Hemal Mehta, Mónica Asencio Duran, Walid Bougamha, Ester Carreño, Francesco Viola, David Squirrell, Daniel Barthelmes, Mark GilliesRetina>DME>FRB54
Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry StudyMay-2022CorneaPUBMEDBlanca Benito-Pascual, Himal Kandel, Marco Abbondanza, Richard Mills, Laurence Sullivan, Stephanie L WatsonCornea>Keratoconus>FCBC11
Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! RegistryMay-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Sanjeeb Bhandari, Hemal Mehta, Francesco Viola, Jennifer Arnold, Samantha Fraser-Bell, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>DME>FRB40
Quality of life impact of eye diseases: a Save Sight Registries studyMay-2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Vuong Nguyen, Stefano Piermarocchi, Lala Ceklic, Kelvin Teo, Francisco Arnalich-Montiel, Stefania Miotto, Vincent Daien, Mark C Gillies, Stephanie L WatsonRetina>AMD|Retina>DME|Cornea>Keratoconus|Retina>RVO>FRB>FCB53
International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registryApr-2022RetinaPUBMEDJavier Zarranz-Ventura, Vuong Nguyen, Catherine Creuzot-Garcher, Frank Verbraak, Louise O Toole, Alessandro Invernizzi, Francesco Viola, David Squirrel, Daniel Barthelmes, Mark C Gillies, from the FRB International committeeRetina>AMD|Retina>DME|Retina>RVO>FRB50
Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgeryApr-2022Clinical and Experimental OphthalmologyPUBMEDDavid P Holmes, Colin I Clement, Vuong Nguyen, Paul R Healey, Ridia Lim, Andrew White, Joshua Yuen, Mitchell LawlorGlaucoma>FGBG2
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! RegistryApr-2022Ophthalmology and TherapyPUBMEDSanjeeb Bhandari, Pierre-Henry Gabrielle, Vuong Nguyen, Vincent Daien, Francesco Viola, Walid Bougamha, Stephanie Young, Barbara Romero-Nuñez, Marc Figueras-Roca, Javier Zarranz-Ventura, Daniel Barthelmes, Laura Sararols, Mark Gillies, Catherine Creuzot-GarcherRetina>DME>FRB55
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomesApr-2022Clinical and Experimental OphthalmologyPUBMEDJavier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, Laura Sararols, Gonzaga Garay-Aramburu, Martín Puzo, Carolina Arruabarrena, Marc Figueras-Roca, Mark C Gillies, Ricardo P Casaroli-Marano, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users GroupRetina>AMD>FRBES2
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistryMar-2022EyePUBMEDSanjeeb Bhandari, David Squirrell, Vuong Nguyen, Nancy Wang, Jane M Wells, Terence Tan, Rachel Barnes, Richard Barry, Daniel Barthelmes, Mark GilliesRetina>DME>FRB43
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! RegistryFeb-2022Acta OphthalmologicaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, Lucia Miguel, Socorro Alforja, Laura Sararols, Ricardo P Casaroli-Marano, Javier Zarranz-Ventura, Mark Gillies, Jennifer Arnold, Daniel BarthelmesRetina>CNV>FRB45
The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degenerationJan-2022RetinaPUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Chui Ming Gemmy Cheung, Jennifer J Arnold, Fred K Chen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB47
The Save Sight Keratoconus Registry - Optometry Module: an opportunity to use real-world data to advance eye careJan-2022Clinical and Experimental OphthalmologyPUBMEDHimal Kandel, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC10
Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry StudyDec-2021CorneaPUBMEDHimal Kandel, Vuong Nguyen, Alex C Ferdi, Aanchal Gupta, Marco Abbondanza, Laurence Sullivan, Andrew Apel, Stephanie L WatsonCornea>Keratoconus>FCBC9
Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! RegistryNov-2021BMJ Open OphthalmologyPUBMEDMitchell Lawlor, Vuong Nguyen, Anne Brooks, Colin Clement, Jamie E Craig, Helen Danesh-Meyer, Ivan Goldberg, Stuart L Graham, John R Grigg, Frank Howes, Ridia Lim, Simon E Skalicky, Andrew J White, Mark GilliesGlaucoma>FGBG1
Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal FibrosisNov-2021Translational vision science & technologyPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Jennifer J Arnold, Sanjeeb Bhandari, Francesco Viola, Odette A M Tigchelaar-Besling, Gonzaga Garay-Aramburu, Louise O'Toole, Chui Ming Gemmy Cheung, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark GilliesRetina>AMD>FRB49
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidenceOct-2021EyePUBMEDKelvin Yi Chong Teo, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Mark C Gillies, Chui Ming Gemmy CheungRetina>AMD>FRB42
Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the NetherlandsSep-2021Acta OphthalmologicaPUBMEDFrank D Verbraak, Dirk L Ponsioen, Odette A M Tigchelaar-Besling, Vuong Nguyen, Mark C Gillies, Daniel Barthelmes, Caroline C W KlaverRetina>AMD>FRBNL1
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registrySep-2021Clinical & Experimental OphthalmologyPUBMEDVuong Nguyen, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterAug-2021Clinical and Experimental OphthalmologyPUBMEDElisa E Cornish, Vuong Nguyen, Stephanie Young, Samantha Fraser-Bell, Robyn Guymer, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB46
Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGFJul-2021RetinaPUBMEDVuong Nguyen, Martin Puzo, Jorge Sanchez-Monroy, Pierre-Henry Gabrielle, Catherine C Garcher, Florian Baudin, Benjamin Wolff Laurent Castelnovo, Guillaume Michel, Louise O'Toole, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB41
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registryJun-2021Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDMarc Figueras-Roca, Alba Parrado-Carrillo, Vuong Nguyen, Ricardo P Casaroli-Marano, Aina Moll-Udina, Mark C Gillies, Daniel Barthelmes, Javier Zarranz-VenturaRetina>AMD>FRBES1
Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal EctasiaJan-2021Asia-Pacific Journal of OphthalmologyPUBMEDPauline Khoo, Maria Cabrera-Aguas, Stephanie L WatsonCornea>Keratoconus>FCBC7
Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! ProjectJan-2021RetinaPUBMEDElisa E Cornish, Kelvin Y Teo, Vuong Nguyen, David Squirrel, Stephanie Young, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB35
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular DegenerationDec-2020JAMA OphthalmologyPUBMEDRobert P Finger, Marie-Therese Puth, Matthias Schmid, Daniel Barthelmes, Robyn H Guymer, Mark GilliesRetina>AMD>FRB39
Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degenerationDec-2020RetinaPUBMEDKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, Alessandro Invernizzi, Jennifer J Arnold, Daniel Barthelmes, Mark GilliesRetina>AMD>FRB34
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! RegistrySep-2020Ophthalmology RetinaPUBMEDPierre-Henry Gabrielle, Vuong Nguyen, Benjamin Wolff, Rohan Essex, Stephanie Young, Adrian Hunt, Chui Ming Gemmy Cheung, Jennifer J Arnold, Daniel Barthelmes, Catherine Creuzot-Garcher, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>FRB38
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020Clinical and Experimental OphthalmologyPUBMEDShaan Wiryasaputra, Vuong Nguyen, Jennifer J Arnold, Ross Ferrier, Peter Hinchcliffe, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB37
Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degenerationSep-2020RetinaPUBMEDAlexander F Vittorio, Vuong Nguyen, Daniel Barthelmes, Jennifer J Arnold, Chui M G Cheung, Neil Murray, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB28
Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight RegistriesSep-2020Journal Franc?ais d'OphtalmologiePUBMEDM Tessier, C Meillon, C Creuzot-Garcher, A M Bron, P NguyenRetina>DME>FRBFR2
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS StudySep-2020Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y Wong, Mark C Gillies, Usha Chakravarthy, Chui Ming Gemmy CheungRetina>AMD>FRBSG1
Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! RegistryAug-2020Clinical and Experimental OphthalmologyPUBMEDAnne C Biechl, Sanjeeb Bhandari, Vuong Nguyen, Jennifer J Arnold, Stephanie Young, Samantha Fraser-Bell, Hemal Mehta, Mark Gillies, Daniel BarthelmesRetina>DME>FRB36
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! projectAug-2020British Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! investigatorsRetina>AMD>FRB32
Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!Jul-2020Journal Franc?ais d'OphtalmologiePUBMEDLestable L, Gabrielle PH, Bron AM, Nguyen P, Creuzot-Garcher CRetina>AMD>FRBFR1
Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French studyJul-2020Clinical and Experimental OphthalmologyPUBMEDBenjamin Wolff, Valerie Macioce, Vivien Vasseur, Laurent Castelnovo, Guillaume Michel, Vuong Nguyen, Vincent Daien, Martine Mauget-Faÿsse, Mark GilliesRetina>AMD>FRBFR3
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! RegistryMay-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel BarthelmesRetina>DME>FRB33
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! RegistryMay-2020Clinical and Experimental OphthalmologyPUBMEDSanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, David Squirrell, Hemal Mehta, Daniel Barthelmes, Mark C GilliesRetina>DME>FRB31
Assessing the accuracy of a large observational registry of neovascular age-related macular degenerationMay-2020RetinaPUBMEDVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, David Squirrell, Rohan Essex, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB25
The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital SettingApr-2020CorneaPUBMEDAlex C Ferdi 1, Vuong Nguyen 1, Chameen Samarawickrama 2, Alex Hamilton 3, Season Yeung 2, Stephanie L Watson 1Cornea>Keratoconus>FCBC6
Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! RegistryMar-2020OphthalmologyPUBMEDSanjeeb Bhandari, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Gayatri Banerjee, Mark Gillies, Daniel BarthelmesRetina>AMD>FRB30
Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry StudyMar-2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Alex Ferdi, Richard Mills, Jern Yee Chen, Adam Watson, Alexander Poon, Laura E Downie, Stephanie L WatsonCornea>Keratoconus>FCBC5
Measurement of Quality of Life in KeratoconusMar-2020CorneaPUBMEDHimal Kandel, Konrad Pesudovs, Stephanie L WatsonCornea>Keratoconus>FCBC4
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsFeb-2020American Journal of OphthalmologyPUBMEDMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, Rohan W Essex, Stephanie Young, David Squirrell, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRB29
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 monthsSep-2019British Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Kelvin Teo, Vuong Nguyen, Mark Daniell, David Squirrell, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB23
Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 MonthsAug-2019Ophthalmology RetinaPUBMEDVuong Nguyen, Anagha Vaze, Samantha Fraser-Bell, Jennifer Arnold, Rohan W Essex, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB27
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! ProjectAug-2019American Journal of OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Kelvin Teo, Daniel Barthelmes, Adrian Fung, Andrea Vincent, Mark GilliesRetina>CNV>FRB26
Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based studyAug-2019British Journal of OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Vincent Daien, Sarah Steinmann, Richard Walton, Mark C Gillies, Daniel BarthelmesRetina>AMD>FRB21
Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 EyesJul-2019OphthalmologyPUBMEDAlex C Ferdi, Vuong Nguyen, Daniel M Gore, Bruce D Allan, Jos J Rozema, Stephanie L WatsonCornea>Keratoconus>FCBC3
Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor AgentsMay-2019OphthalmologyPUBMEDChu Luan Nguyen, Mark C Gillies, Vuong Nguyen, Vincent Daien, Amy Cohn, Gayatri Banerjee, Jennifer Arnold, Fight Retinal Blindness! Study GroupRetina>AMD>FRB24
Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry StudyMay-2019CorneaPUBMEDJeremy C K Tan, Vuong Nguyen, Eva Fenwick, Alex Ferdi, Amanda Dinh, Stephanie L WatsonCornea>Keratoconus>FCBC1
Clinical Registries in OphthalmologyMay-2019OphthalmologyPUBMEDJeremy C K Tan, Alexander C Ferdi, Mark C Gillies, Stephanie L WatsonCornea|Retina>FRB>FCBC2
A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! CohortMar-2019Ophthalmology RetinaPUBMEDKelvin Yi Chong Teo, David M Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung, Mark GilliesRetina>FRB22
Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular DegenerationJan-2019OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn Guymer, Stephanie Young, Alex Hunyor, Samantha Fraser-Bell, Adrian Hunt, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB20
A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! ProjectOct-2018Graefe’s Archive for Clinical and Experimental OphthalmologyPUBMEDDaniel Barthelmes, Vuong Nguyen, Richard Walton, Mark C Gillies, Vincent Daien, Fight Retinal Blindness Study GroupRetina>AMD>FRB19
Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational StudyOct-2018RetinaPUBMEDAnagha Vaze, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Stephanie H Young, Chui M Cheung, Ecosse Lamoureux, Mayuri Bhargava, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRBAU4
Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! ProjectJun-2018American Journal of OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Nigel Morlet, Jennifer J Arnold, Rohan W Essex, Stephanie Young, Alex Hunyor, Mark C Gillies, Daniel Barthelmes, Fight Retinal Blindness! Study GroupRetina>AMD>FRB18
Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational StudyJun-2018Ophthalmology RetinaPUBMEDEugene A Lowry, Vuong Nguyen, Vincent Daien, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB17
Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licenceMay-2018Clinical and Experimental OphthalmologyPUBMEDMehmet Ozturk, Martin L Harris, Vuong Nguyen, Daniel Barthelmes, Mark C Gillies, Hemal MehtaRetina>AMD>FRBUK1
Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set.Apr-2018Clinical and Experimental OphthalmologyPUBMEDVuong Nguyen, Vincent Daien, Robyn H Guymer, Ian L McAllister, Nigel Morlet, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB16
Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular DegenerationFeb-2018OphthalmologyPUBMEDAlessandro Invernizzi, Vuong Nguyen, Jennifer Arnold, Stephanie Young, Daniel Barthelmes, Mark C GilliesRetina>AMD>FRB15
Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular DegenerationJan-2018OphthalmologyPUBMEDVincent Daien, Vuong Nguyen, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness! Study GroupRetina>AMD>FRB14
Two year outcomes of "treat and extend" intravitreal therapy using aflibercept preferentially for neovascular age-related macular degenerationJan-2018RetinaPUBMEDDaniel Barthelmes, Vuong Nguyen, Vincent Daien, Anna Campain, Richard Walton, Robyn Guymer, Nigel Morlet, Alex P Hunyor, Rohan W Essex, Jennifer J Arnold, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB11
Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsMar-2017OphthalmologyPUBMEDMark C Gillies, Vincent Daien, Vuong Nguyen, Daniel BarthelmesRetina>AMD>FRBAU3
Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMDFeb-2017OphthalmologyPUBMEDHessom Razavi, Richard Walton, Mark Gillies, Robyn Guymer, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB13
Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational StudyDec-2016Ophthalmology PUBMEDMark C Gillies, Vuong Nguyen, Vincent Daien, Jennifer J Arnold, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB12
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDec-2016British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Anna Campain, Phuc Nguyen, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB9
Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular DegenerationNov-2016OphthalmologyPUBMEDRohan W Essex, Vuong Nguyen, Richard Walton, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Nigel Morlet, Stephanie Young, Daniel Barthelmes, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB10
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational StudySep-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Daniel Barthelmes, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Rohan W Essex, Nigel Morlet, Alex P Hunyor, Fight Retinal Blindness Study GroupRetina>AMD>FRB8
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJun-2015OphthalmologyPUBMEDJennifer J Arnold, Anna Campain, Daniel Barthelmes, Judy M Simpson, Robyn H Guymer, Alex P Hunyor, Ian L McAllister, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness Study GroupRetina>AMD>FRB7
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMar-2015OphthalmologyPUBMEDMark C Gillies, Anna Campain, Richard Walton, Judy M Simpson, Jennifer J Arnold, Robyn H Guymer, Ian L McAllister, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Daniel Barthelmes, Fight Retinal Blindness Study GroupRetina>AMD>FRB6
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataMar-2015British Journal of OphthalmologyPUBMEDDaniel Barthelmes, Richard Walton, Anna E Campain, Judy M Simpson, Jennifer J Arnold, Ian L McAllister, Robyn H Guymer, Alex P Hunyor, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB3
Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degenerationDec-2014Acta OphthalmologicaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU1
Intravitreal therapy in bilateral neovascular age-related macular degenerationOct-2014OphthalmologyPUBMEDDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Anna Campain, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Mark C Gillies, Fight Retinal Blindness! Project InvestigatorsRetina>AMD>FRB5
Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degenerationSep-2014RetinaPUBMEDAnagha Vaze, Samantha Fraser-Bell, Mark GilliesRetina>AMD>FRBAU2
Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohortMar-2014OphthalmologyPUBMEDMark C Gillies, Richard J Walton, Jennifer J Arnold, Ian L McAllister, Judy M Simpson, Alex P Hunyor, Robyn Guymer, Rohan W Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB4
Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! ProjectJan-2014RetinaPUBMEDMark C Gillies, Richard Walton, Julines Liong, Jennifer J Arnold, Ian McAllister, Nigel Morlet, Alex Hunyor, Robyn Guymer, Jill Keeffe, Rohan Essex, Amparo Herrera-Bond, Briony Glastonbury, Judy M Simpson, Daniel BarthelmesRetina>AMD>FRB1
Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve EyesAug-2013Investigative Ophthalmology and Visual SciencePUBMEDMark C. Gillies, Richard Walton, Judy M. Simpson, Jennifer J. Arnold, Robyn H. Guymer, Ian L. McAllister, Alex P. Hunyor, Rohan W. Essex, Nigel Morlet, Daniel BarthelmesRetina>AMD>FRB2